Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Impact of GNA13 overexpression on gene expression changes in LNCaP cells

ABSTRACT: GNA13 has been shown to have multiple oncogenic roles in many different solid tumors including prostate cancers. However, the molecular mechanisms that drive GNA13-induced oncogenesis and metastasis is not understood completely. To elucidate the mechanisms driven by GNA13 in prostate cancer cells, we performed total RNA sequencing in LNCaP cells after overexpressing the wild-type GNA13 cDNA in a pBabe-puromycin vector.

ORGANISM(S): Homo sapiens

PROVIDER: GSE263633 | GEO | 2025/06/04

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Impact of GNA13 knockdown on gene expression changes in PC3 cells

Project description:GNA13 has been shown to have multiple oncogenic roles in many different solid tumors including prostate cancers. However, the molecular mechanisms that drive GNA13-induced oncogenesis and metastasis is not understood completely. To elucidate the mechanisms driven by GNA13 in prostate cancer cells, we performed total RNA sequencing in PC3 cells after knocking down GNA13 expression using two different shRNAs.

2019-12-31 | GSE133893 | GEO

Impact of BHLHE40-AS1 over expression in MCF10A cells

Project description:BHLHE40-AS1 was cloned into pBABE-Puro. Empty vector and pBABE-BHLHE40-AS1 were used to generate retrovirus and infect MCF10A cells. Transduced cells were selected with 1ug/mL puromycin for 2 weeks.

2020-06-10 | GSE136579 | GEO

Impact of GNA13 overexpression on gene expression changes in LNCaP cells

Project description:Impact of GNA13 overexpression on gene expression changes in LNCaP cells

| PRJNA1098605 | ENA

Knockdown of DHRS7 in LNCaP cells

Project description:Knockdown of DHRS7 in the prostate cancer cell line LNCaP was performed for 24h, 36h, and 48h using siRNA.

2022-07-07 | PXD031229 | Pride

Impact of BCL2 inhibitor Venetoclax on LNCaP cells

Project description:In analyzing transcriptomic data from a clinical trial of neoadjuvant-intensive Androgen Deprivation Therapy, we observed increased mRNA expression of the hallmark antiapoptotic gene BCL2 in the prostate tumors of treated patients versus those of untreated patients. We showed that BCL2 overexpressed LNCaP cells exhibited resistance to enzalutamide, indicating that BCL2-overexpression leads to castration resistance and cellular plasticity.We treted the LNCaP cells with Bcl2 inhibitor Venetoclax in under castration of in presence of Androgen for 24 hr and observed that androgen supressed Venetoclax function

2025-05-15 | GSE273738 | GEO

Impact of androgen stimulation on BCL2 Overexpressed LNCaP cells

Project description:In analyzing transcriptomic data from a clinical trial of neoadjuvant-intensive Androgen Deprivation Therapy, we observed increased mRNA expression of the hallmark antiapoptotic gene BCL2 in the prostate tumors of treated patients versus those of untreated patients. We showed that BCL2 overexpressed LNCaP cells exhibited resistance to enzalutamide, indicating that BCL2-overexpression leads to castration resistance and cellular plasticity.We performed RNA sequencing on BCL2 overexpressed LNCaP cells tretaed with R1881 to determine BCL2 regulated AR signaling and overed that BCL2 overexpression may alter AR-pathway.

2025-05-15 | GSE273737 | GEO

LNCaP prostate cancer cells

Project description:LNCaP prostate cancer cells

| PRJNA801659 | ENA

Gene expression of LNCaP human prostate cells by cholesterol diet

Project description:Understanding the systemic regulation of normal prostate gene expression by cholesterol diet is critical for deciphering the mechanisms responsible for the transition from healthy to pathogenic prostate conditions. To understand mechanism under cholesterol effect on prostate, we performed microarray analysis using LNCaP human prostate cells cultured in low cholesterol medium. The RNA is obtained from LNCaP human prostate cells serum-starved for 0h, 3h, 16h followed by CLM medium.

2011-12-01 | E-GEOD-25472 | biostudies-arrayexpress

R1881 treatment modulates LNCaP proteome.

Project description:The androgen receptor is considered as the key promoter of prostate cancer. It is a transcription factor that controls the transcription of hundreds of its target genes. In this project we focuses on how androgen receptor stimulation by the synthetic androgen R1881 can affect the proteome of peroxiosmes and the antioxidant enzymes in LNCaP cells.

2024-11-01 | PXD054374 | Pride

lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line

Project description:We generated and characterized an androgen-independent LNCaP-AI cell line by long-term culture of androgen-dependent LNCaP cells in RPMI-1640 medium containing charcoal-stripped serum. This approach used to generate the line mimics the castration resistant condition for treating prostate cancer, supporting the relevance of the LNCAP-AI cell line to Castration Resistant Prostate Cancer.

2019-01-01 | GSE124519 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data